Episodes
Saturday Mar 02, 2024
Saturday Mar 02, 2024
Pharmacists are the most accessible health professionals and can play a vital role in screening and managing hypertension. But would an expanded scope of practice that enabled pharmacists to prescribe and manage antihypertensive therapies be cost-effective?
Guest Authors: Stefania Cian, PharmD and Candice Garwood, PharmD, FCCP, BCPS, BCACP
Special Guest: Dave Dixon, PharmD, BCACP, CLS
Music by Good Talk
Friday Feb 02, 2024
Friday Feb 02, 2024
Most clinical settings now use oscillometric BP devices to measure patients’ BP, and over half of people with hypertension (HTN) use a home BP monitor. Can we trust these BP readings if an inappropriate cuff size was used? How will this impact the way we assess BP control?
Guest Authors: Vincent Lam, PharmD and Kathleen Pincus, PharmD, BCPS, BCACP, CDCES
Music by Good Talk
Friday Dec 01, 2023
Complex Patient Case 3: Treatment Resistant Hypertension
Friday Dec 01, 2023
Friday Dec 01, 2023
Reason for Visit: JT was referred by his PCP to the ambulatory care pharmacist for hypertension management.
Chief complaint: “My medication is making my mouth dry. I want to stop it.”
Guest Authors: Sabrina Silviera, PharmD and Megan Scalia, PharmD, BCACP
Expert Panelists: Eric MacLaughlin, PharmD, BCPS and Joseph Saseen, PharmD, BCPS, BCACP, CLS
Music by Good Talk
Friday Nov 03, 2023
Is Telehealth the Hidden (Hyper)Link to Controlling Blood Pressure?
Friday Nov 03, 2023
Friday Nov 03, 2023
Do pharmacists providing remote care using telehealth technologies to patients who self-monitor their blood pressure perform as well as physicians and care managers providing care face-to-face? Is BP control better (or worse)? What about patient satisfaction? The Hyperlink 3 study provides more evidence the telehealth is safe and effective ... and patients prefer it.
Guest Authors: Elizabeth Yett, PharmD, BCACP, TTS, and Jessica Wooster, PharmD, BCACP
Music by Good Talk
Friday Oct 20, 2023
Friday Oct 20, 2023
Less than 1 in 4 patients with hypertension in the United States have achieved their blood pressure (BP) goal, according to the CDC. Many clinicians only think of changing medications if a patient is having an intolerance to the current regimen. However, individual patients might respond differently to each of the four major anti-hypertensive medication classes and, if we could determine in advance which class(es) would lower the blood pressure the most, we could minimize the number of medications eventually needed to attain control.
Guest Author: Anthony Ishak, PharmD, BCPS
Music by Good Talk
Friday Feb 03, 2023
Friday Feb 03, 2023
Hyperkalemia is a common electrolyte disorder in patients with CKD that can be exacerbated by renin-angiotensin-aldosterone system (RAAS) inhibitors. While hyperkalemia poses potential risks to patients with CKD, the potentially negative impact of discontinuing RAAS inhibitor therapy on long-term renal and cardiovascular outcomes in CKD patients is unclear.
Guest Author: Michelle A. Fravel, PharmD, BCPS
Music by Good Talk
Friday Sep 02, 2022
Treating mild hypertension during pregnancy: Time for a new CHAPter!
Friday Sep 02, 2022
Friday Sep 02, 2022
Most practitioners won’t hesitate to start drug therapy in an adult patient with chronically elevated blood pressure (BP) … except, perhaps, if the patient is pregnant. In this vulnerable population, we frequently take a “wait-and-see” approach and withhold therapy unless the BP elevations become severe. But is this the right decision?
Guest Authors: Timothy D. Gladwell, PharmD, BCPS, BCACP and Scott Baker, PharmD, BCPS
Music by Good Talk
Friday Aug 05, 2022
Managing Pain in Patients with High Blood Pressure: Is There No Safe PATH?
Friday Aug 05, 2022
Friday Aug 05, 2022
Pain and hypertension are two of the most prevalent conditions worldwide. Acetaminophen is often considered the “go-to” and the “safe” over-the-counter analgesic for patients with hypertension because it is not commonly believed to increase blood pressure or cardiovascular events. But is that assumption grounded in evidence?
Guest Authors: Lizzie Baumeister, PharmD and Austin Morgan, PharmD, BCACP, CDCES
Music by Good Talk
Friday Mar 25, 2022
Thiazides in Chronic Kidney Disease: New Evidence Challenging Old Dogma
Friday Mar 25, 2022
Friday Mar 25, 2022
Thiazide diuretics have been in clinical use for more than 60 years. Small studies published in the 1950s/60s reported that chlorothiazide had less diuretic and antihypertensive effect in patients with lower glomerular filtration rates which led to the belief that thiazides are ineffective in advanced CKD. The Chlorthalidone in Chronic Kidney Disease (CLICK) Trial challenges this dogma.
Guest Authors: Michael Ernst, PharmD, BCGP and Michelle A. Fravel, PharmD, BCPS
Music by Good Talk
Friday Mar 11, 2022
Friday Mar 11, 2022
Traditionally, hypertension management involves a stepwise approach where agents are titrated and added. Thus, achieving optimal BP control requires close follow-up, time, and resources. Outside of these logistics, providers are prone to clinical inertia (aka fail to advance therapy when they should) and sometimes “push back” from patients who experience the burdens of treatment and follow-up. Perhaps it’s time to reconsider our approach to managing hypertension.
Guest Authors: Erin Connolly, PharmD and Laura Varnum, PharmD, BCACP
Music by Good Talk